Free Trial

Marker Therapeutics (MRKR) News Today

Marker Therapeutics logo
$3.38 -0.04 (-1.17%)
(As of 05:10 PM ET)
Marker Therapeutics sells 5.03M shares at $3.20 in private placement
Marker Therapeutics Advances in Clinical Trials and Finances
Jason Marker
AML cell therapy trials to watch in 2024 targeting GvHD
Marker Therapeutics, Inc. stock logo
Marker Therapeutics (NASDAQ:MRKR) Trading Up 5%
Marker Therapeutics (NASDAQ:MRKR) Shares Up 5%
Reinstalling a Midstate Marker
Marker Therapeutics Inc (MRKR)
Get Marker Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for MRKR and its competitors with MarketBeat's FREE daily newsletter.

Could This Tiny Device Help You Make an Extra $30k a Year? (Ad)

I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.

Click here to see the details because I believe a lot of people will get rich.

MRKR Media Mentions By Week

MRKR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MRKR
News Sentiment

0.93

0.55

Average
Medical
News Sentiment

MRKR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MRKR Articles
This Week

5

1

MRKR Articles
Average Week

Get Marker Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for MRKR and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:MRKR) was last updated on 12/24/2024 by MarketBeat.com Staff
From Our Partners